New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
RNA key in helping stem cells know what to become

RNA key in helping stem cells know what to become

byUniversity of Colorado at BoulderCredit: CC0 Public DomainLook deep inside our cells, and you'll find that each has an identical genome -a complete set of genes that provides the instructi
World medicine November 30,2023
RNA key in helping stem cells know what to become

RNA key in helping stem cells know what to become

byUniversity of Colorado at BoulderCredit: CC0 Public DomainLook deep inside our cells, and you'll find that each has an identical genome -a complete set of genes that provides the instructi
World medicine November 30,2023
Are sodium-glucose cotransporter-2 inhibitors safe for patients with diabetes and cancer?

Are sodium-glucose cotransporter-2 inhibitors safe for patients with diabetes and cancer?

byAmerican Society of NephrologyCredit: Pixabay/CC0 Public DomainSodium-glucose cotransporter-2 inhibitors (SGLT2i) have heart- and kidney-related benefits for patients with and without diabetes
World medicine November 30,2023
Are sodium-glucose cotransporter-2 inhibitors safe for patients with diabetes and cancer?

Are sodium-glucose cotransporter-2 inhibitors safe for patients with diabetes and cancer?

byAmerican Society of NephrologyCredit: Pixabay/CC0 Public DomainSodium-glucose cotransporter-2 inhibitors (SGLT2i) have heart- and kidney-related benefits for patients with and without diabetes
World medicine November 30,2023
RNA regulation is crucial for embryonic stem cell differentiation

RNA regulation is crucial for embryonic stem cell differentiation

by Lisbeth Heilesen,Aarhus UniversityA functional link between nuclear RNA decay and transcriptional control by the Polycomb Repressive Complex 2. In the absence of PAXT-mediated RNA decay, nucl
World medicine November 30,2023
RNA regulation is crucial for embryonic stem cell differentiation

RNA regulation is crucial for embryonic stem cell differentiation

by Lisbeth Heilesen,Aarhus UniversityA functional link between nuclear RNA decay and transcriptional control by the Polycomb Repressive Complex 2. In the absence of PAXT-mediated RNA decay, nucl
World medicine November 30,2023
New NK cell engaging immunotherapy approaches to target and potentially treat recalcitrant ovarian cancer

New NK cell engaging immunotherapy approaches to target and potentially treat recalcitrant ovarian cancer

byThe Wistar InstituteCredit: CC0 Public DomainThe Wistar Institute's David B. Weiner and collaborators have engineered novel monoclonal antibodies that engage natural killer (NK) cells thro
World medicine November 30,2023
New NK cell engaging immunotherapy approaches to target and potentially treat recalcitrant ovarian cancer

New NK cell engaging immunotherapy approaches to target and potentially treat recalcitrant ovarian cancer

byThe Wistar InstituteCredit: CC0 Public DomainThe Wistar Institute's David B. Weiner and collaborators have engineered novel monoclonal antibodies that engage natural killer (NK) cells thro
World medicine November 30,2023
RNA discoveries could improve stem cell research

RNA discoveries could improve stem cell research

by Will Doss,Northwestern UniversityA hairpin loop from a pre-mRNA. Highlighted are the nucleobases (green) and the ribose-phosphate backbone (blue). Note that this is a single strand of RNA tha
World medicine November 30,2023
RNA discoveries could improve stem cell research

RNA discoveries could improve stem cell research

by Will Doss,Northwestern UniversityA hairpin loop from a pre-mRNA. Highlighted are the nucleobases (green) and the ribose-phosphate backbone (blue). Note that this is a single strand of RNA tha
World medicine November 30,2023
How to reduce your risk of gynecological cancer

How to reduce your risk of gynecological cancer

by Chad A. Hamilton, Ochsner HealthCredit: Pixabay/CC0 Public DomainThe American Cancer Society estimates about 115,000 women will be diagnosed with a gynecologic cancer this year. That's one case
World medicine November 30,2023
How to reduce your risk of gynecological cancer

How to reduce your risk of gynecological cancer

by Chad A. Hamilton, Ochsner HealthCredit: Pixabay/CC0 Public DomainThe American Cancer Society estimates about 115,000 women will be diagnosed with a gynecologic cancer this year. That's one case
World medicine November 30,2023
Genetic switches in tumor development may lead to new therapeutic target for colorectal cancer

Genetic switches in tumor development may lead to new therapeutic target for colorectal cancer

byKanazawa UniversityEffects of gene mutations on tumor development. Credit:Cancer Research(2023). DOI: 10.1158/0008-5472.CAN-23-1490Researchers at Kanazawa University report in&nbsp
World medicine November 30,2023
Genetic switches in tumor development may lead to new therapeutic target for colorectal cancer

Genetic switches in tumor development may lead to new therapeutic target for colorectal cancer

byKanazawa UniversityEffects of gene mutations on tumor development. Credit:Cancer Research(2023). DOI: 10.1158/0008-5472.CAN-23-1490Researchers at Kanazawa University report in&nbsp
World medicine November 30,2023
Study: Pembrolizumab + chemo, trastuzumab beneficial in gastroesophageal cancer

Study: Pembrolizumab + chemo, trastuzumab beneficial in gastroesophageal cancer

by Elana GotkineFor patients with HER2-positive gastroesophageal junction (GEJ) adenocarcinoma, pembrolizumab improves progression-free survival when combined with chemotherapy and trastuzumab, accord
World medicine November 30,2023
Study: Pembrolizumab + chemo, trastuzumab beneficial in gastroesophageal cancer

Study: Pembrolizumab + chemo, trastuzumab beneficial in gastroesophageal cancer

by Elana GotkineFor patients with HER2-positive gastroesophageal junction (GEJ) adenocarcinoma, pembrolizumab improves progression-free survival when combined with chemotherapy and trastuzumab, accord
World medicine November 30,2023
Caveolin binding motif in Na/K-ATPase is required for stem cell differentiation, organogenesis in animals

Caveolin binding motif in Na/K-ATPase is required for stem cell differentiation, organogenesis in animals

by Marshall UniversityCaenorhabditis elegans. Credit: WikipediaNew findings reveal the importance of the Na/K-ATPase protein in stem cell differentiation and organogenesis, in a study led by scientist
World medicine November 30,2023
Caveolin binding motif in Na/K-ATPase is required for stem cell differentiation, organogenesis in animals

Caveolin binding motif in Na/K-ATPase is required for stem cell differentiation, organogenesis in animals

by Marshall UniversityCaenorhabditis elegans. Credit: WikipediaNew findings reveal the importance of the Na/K-ATPase protein in stem cell differentiation and organogenesis, in a study led by scientist
World medicine November 30,2023
Study shows no increase in cancer risk for most patients with reflux disease

Study shows no increase in cancer risk for most patients with reflux disease

byKarolinska InstitutetCredit: Pixabay/CC0 Public DomainReflux disease manifests as acid regurgitation and heartburn and is a known risk factor for esophageal cancer. However, a new study publis
World medicine November 30,2023
Study shows no increase in cancer risk for most patients with reflux disease

Study shows no increase in cancer risk for most patients with reflux disease

byKarolinska InstitutetCredit: Pixabay/CC0 Public DomainReflux disease manifests as acid regurgitation and heartburn and is a known risk factor for esophageal cancer. However, a new study publis
World medicine November 30,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com